Logo
Logo

About Metoprolol Succinate API

Product
  • Therapeutic CategoryCardiovascular-pt

  • CAS Number

    98418-47-4

  • API Technology

    Synthetic

  • Dose Form

    Oral Solid/Tablets

  • Dr Reddy's Development Status

    Available

  • Available Regulatory Filing

    USDMF, CEP Submitted, Brazil DMF, Canada DMF, China DMF

Mechanism of Action

Several possible mechanisms have been proposed:

 

  • Competitive antagonism of catecholamine at peripheral (especially cardiac) adrenergic neuron sites, leading to decreased cardiac output;
  • A central effect leading to reduced sympathetic outflow to the periphery; and
  • Suppression of renin activity.

 

Indication

 

  • Hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions.
  • Angina Pectoris.
  • Heart Failure - for the treatment of stable, symptomatic (NYHA Class II or III) heart failure of ischemic, hypertensive, or cardiomyopathic origin.

 

Related APIs

Mavacamten -Portugese

Cardiovascular-pt

arrow

Request for Quotation

Get in touch with us by filling out the form below. Our team will reach out to you shortly!

Phone
Disclaimer: Products under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act (Bolar Exemption) and not for commercial sale.